Oxalin Junior (Oxymetazoline Hydrochloride)

Oxymetazoline hydrochloride, the active ingredient in Oxalin Junior, is an alpha‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion by constricting blood vessels in the nasal mucosa, providing temporary relief in children. Oxalin Junior is supplied by GNH USA as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxalin Junior as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxalin Junior contains oxymetazoline, an alpha‑adrenergic decongestant that acts on nasal mucosal vessels. - Nasal congestion due to the common cold: provides temporary relief of blockage. - Allergic rhinitis in children: reduces swelling and improves airflow. - Sinus pressure associated with upper‑respiratory infections: eases discomfort and aids drainage.

Oxalin Junior may cause local and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Nasal dryness - Mild burning or stinging sensation - Sneezing - Headache - Transient taste alteration

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration - Elevated blood pressure - Tachycardia - Severe headache or facial pain - Allergic reaction such as rash, itching, or swelling

When using Oxalin Junior, consider the following safety measures: - Age restriction:              ...   r   ...  -    g  ...   ewline  ...  -  t  ewline   ewline  ewline  ewline  ewline  ewline  ewline  ewline  ewline  ewline  ewline \n"

The        ... ...